Checking a new blood test marker in the ER
Part of Infections clinical trials.
This study looks at a new marker called MDW that might help doctors find infections faster. It checks how well it works in adults coming to the emergency room.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 89 years old
- You went to the emergency room
- A blood sample was taken during your ER visit
- Your blood was tested within 2 hours of collection
- You were in the ER (or hospital) for at least 12 hours after arriving
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new blood test (Microbio InfectID-BSI) to see how well it detects bacteria and yeast in patients with a possible bloodstream infection. If you are already having a blood culture done, the study will collect extra blood samples at the same time to compare the new test's results.
This study aims to find new ways to quickly diagnose sepsis (a severe response to infection) in patients arriving at the emergency room. If successful, these new tests could help doctors start treatment faster.
This study tests whether a special blood test can help doctors quickly identify patients who have serious infections (sepsis) in the emergency department. The test looks at white blood cells that glow under fluorescent light to see if they can predict which patients are at highest risk.
This trial is testing whether a new, highly sensitive blood test (droplet digital PCR) combined with genetic analysis can help doctors predict sepsis earlier in emergency room patients. This could lead to faster treatment and better outcomes.
This study looks at blood test “markers” to tell the difference between infection and non-infectious illness. It may help doctors recognize infection earlier and avoid confusion with other conditions.
This trial tests a new, faster way to find bacteria in the blood of children with suspected sepsis. It uses a molecular test that may give results sooner than standard cultures, helping doctors treat infections more quickly.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.